DEA and Seniors' use of Alternative Cannabis Medicine DSM-5 On May 18, 2013, the fifth edition of the American Psychiatric Association's (APA's) Diagnostic and Statistical Manual of Mental Disorders - DSM-5 was published amongst a myriad of controversy and criticism. Not surprising, a big complaint with the fifth revision is with the undue influence that the pharmaceutical industry, or more specifically, the psychiatric drug industry had with the revision. The criticism stems from the fact that over 70% of the task force members responsible for the revision and assigned by the APA, were from the pharmaceutical industry. Cannabis Use Disorder The DSM-5 does not separate the diagnosis of cannabis abuse from cannabis dependence anymore. Instead, the new DSM-5 has come up with specific criteria for diagnosing intoxication, withdrawal, substance/medication-induced disorders, and a new category in which "unspecified substance-induced disorders, where t...